Project Grant R01NS140155

Award Date 5/15/25
Completion Date 4/30/29
Dollars Obligated $669K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Cincinnati, OH 45221, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to advance the development of prognostic and monitoring biomarkers for neutrophil-driven secondary brain injury in spontaneous intracerebral hemorrhage (SICH). The $704,313 award, with a project period from December 1, 2024 to November 30, 2026, will support research to define and...
This Project Grant award of $2,403,545 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders federal grant program (CFDA 93.853), supports research to examine the epigenetic mechanisms linking social determinants of health (SDOH) exposures to vascular cognitive impairment and dementia (VCID) after intracerebral hemorrhage (ICH) stroke. The research, titled REACH-EPIVCID, will identify...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $537,508 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program to The Research Foundation For The State University Of New York, doing business as Stony Brook University. This 5-year award (12/1/2024 - 11/30/2029) supports research to elucidate the role of endogenously formed zinc protoporphyrin (ZnPP) in brain damage following intracerebral hemorrhage...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will provide $617,687 to the University of Texas Health Science Center at Houston to build infrastructure for community-engaged research interventions focused on three neurologic conditions affecting brain health: stroke, vascular cognitive impairment and dementia, and Parkinson's...
This $624,583 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support research at the University of Washington to identify potential therapeutic targets for preventing ischemic stroke. The project will leverage existing plasma samples, genomic data, and electronic medical records from the Heart and Vascular Health Study to evaluate...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $666,530 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to Weill Medical College of Cornell University. The objective of this 5-year project is to develop an MRI-based cerebral metabolic rate of oxygen consumption (CMRO2) mapping technique to evaluate ischemic lesion viability in acute stroke patients. The project aims to validate the MRI-based CMRO2...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $591,304.00 to the University of Louisville to conduct research on the role of the integrated stress response (ISR) pathway, particularly the kinase HRI, in oligodendrocyte death and neuroinflammation following traumatic spinal cord injury (SCI). The research aims to elucidate the...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate the role of the CCL2/CCR2 signaling pathway in modulating HIV-associated ischemic stroke severity and recovery. The $422,125 award, effective from September 18, 2024 to August 31, 2026, will be conducted by the University of Miami. The research aims to...
This federal Project Grant award of $169,000 from the National Institute of Neurological Disorders and Stroke (NINDS, CFDA 93.853) will support the development of a comprehensive, open-source, and user-friendly online platform for neurometabolic diseases. The platform will include clinical, biochemical, radiological, and therapeutic data on over 1,600 known neurometabolic diseases. This initiative aims to enhance understanding, clinical management, and research insights into these rare genetic...
This $2,888,616 Cooperative Agreement award from the National Institute of Neurological Disorders and Stroke (NINDS), under CFDA 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders, will fund a multi-institutional effort to analytically validate a panel of 7 emerging blood-based biomarkers for monitoring the temporal evolution of traumatic brain injury (TBI). The project will leverage existing blood samples from large TBI studies to assess pre-analytical...

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $669,092.00 to the University of Cincinnati to conduct a comprehensive metabolomic analysis of 1,273 intracerebral hemorrhage (ICH) participants and matched controls. The goal is to identify specific metabolite biomarkers associated with poor outcomes after ICH, which disproportionately affects Black and Hispanic populations. The research leverages existing samples and data from two large genetic epidemiology studies, ERICH and ROSE, to assess 5,400 metabolites and their relationships to clinical, demographic, neuroimaging, and genetic risk factors for 3-month ICH outcomes. The findings will inform the development of novel therapeutic interventions targeting key metabolic pathways. The project period runs from May 15, 2025 to April 30, 2029.

Generated 7/15/25, 4:00 AM